Up-regulation of kinin B 1 receptor in the lung of streptozotocin-diabetic rat: Autoradiographic and functional evidence

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 13-22

  Vianna, Rose Mari J ^a,c   Ongali, Brice ^a   Regoli, Domenico ^b   Calixto, João Batista ^c   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

B 1 receptor; Bradykinin; Des Arg 9 BK; Diabetes; Hoe140; Inflammation; Leukocyte; Pleurisy

Indexed keywords

ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ[7 DEARGININE]; ICATIBANT; ICATIBANT[10 DEARGININE]; NPC 18884; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPERGLYCEMIA; INFLAMMATION; MALE; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; STREPTOZOCIN DIABETES; TIME; UPREGULATION;

ANIMALS; AUTORADIOGRAPHY; CELL MOVEMENT; DIABETES MELLITUS, EXPERIMENTAL; LEUKOCYTES; LUNG; MALE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; UP-REGULATION;

EID: 0037275496     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704999     Document Type: Article

References (35)

1. ABDOUH, M., KHANJARI, A., COUTURE, R., REGOLI, D. & HASSÉSSIAN, H.M. (2001). Vasodilator bradykinin receptor mechanisms in the retina of Wistar and streptozotocin treated diabetic rats. International Symposium on Peptide Receptors, Montreal, Canada, July 29-August 2, (Abstract P 70).
2. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol., 156, 269-274.
3. 1 receptor-deficient mice. Biol. Chem., 382, 91-95.
4. BÖCKMANN, S. & PAEGELOW, I. (2000). Kinins and kinin receptors: importance for the activation of leukocytes. J. Leukocyte Biol., 68, 587-592.
5. 1 receptor expression by endogenous glucocorticoids hormones in rats. Br. J. Pharmacol., 132, 567-577.
6. 2 receptors in streptozotocin-diabetic rats. Eur. J. Pharmacol., 416, 169-177.
7. 1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor-κB pathways. Br. J. Pharmacol., 127, 1851-1859.
8. CHAKRAVARTY, S., MAVUNKEL, B.J., GOEHRING, R.R. & KYLE, D.J. (1996). Novel bradykinin receptor antagonists from a structurally directed non-peptide combinatorial library. Immunopharmacology, 33, 61-67.
9. 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br. J. Pharmaeol., 130, 375-385.
10. 2 receptors in the spinal cord of spontaneously hypertensive rats. Br. J. Pharmacol., 135, 1641-1654.
11. COUTURE, R., HARRISSON, M., VIANNA, R.M. & CLOUTIER, F. (2001). Kinin receptors in pain and inflammation. Eur. J. Pharmacol., 429, 161-176.
12. 9]-BK in carrageenan-induced edema. Peptides, 17, 1009-1015.
13. 1 receptor-related peptides. Antagonists. Hypertension, 28, 833-839.
14. HUNTER, W.M. & GREENWOOD, F.C. (1962). Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature, 194, 495-496.
15. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
16. KOYAMA, S., SATO, E., NUMANAMI, H., KUBO, K., NAGAI, S. & IZUMI, T. (2000). Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. Am. J. Respir. Cell Mol., Biol., 22, 75-84.
17. 1-receptor-induced hypotension in the anesthetized dog. J. Cardiovasc. Pharmacol., 28, 645-650.
18. 1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can. J. Physiol. Pharmacol., 80, 328-333.
19. 1 receptors: review. Immunopharmacology, 30, 1-26.
20. 1 receptors for kinins. Pharmacol. Rev., 50, 357-386.
21. MASS, J., RAE, A.G., HUIDOBRO-TORO, J. & CALIXTO, J.B. (1995). Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Br. J. Pharmacol., 114, 1471-1477.
22. 1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J. Exp. Med., 192, 367-380.
23. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br. J. Pharmacol., 110, 71-76.
24. NAVARRO, M., FRONTERA, M., ZUCCOLLO, A. & CATANZARO, O. (2001). Nitric oxide (NO) changes accompanying the progression from early insulitis to diabetes. International Symposium on Peptide Receptors, Montreal, Canada, July 29-August 2 (Abstract P 66).
25. 2 receptors in the mouse. Can. J. Physiol. Pharmacol., 73, 1759-1764.
26. 2 receptor mice. Naunyn-Schm. Arch Pharmacol., 357, 191-196.
27. RAYMOND, P., DRAPEAU, G., RAUT, R., AUDET, R., MARCEAU, F., ONG, H. & ADAM, A. (1995). Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J. Immunol. Methods., 180, 247-257.
28. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
29. REGOLI, D., NSA ALLOGHO, S., RIZZI A. & GOBEIL JR., F. (1998). Bradykinin receptors and their antagonists. A review. Eur. J. Pharmacol., 348, 1-10.
30. ROTHSCHILD, A.M., MELO, V.L., REIS, M.L., FOSS, M.C. & GALLO JR., L. (1999). Kininogen and prekallikrein increases in the blood of streptozotocin-diabetic rats are normalized by insulin in vivo and in vitro. Naunyn-Schm. Arch. Pharmacol., 360, 217-220.
31. 2 receptor antagonist. Eur. J. Pharmacol., 363, 179-187.
32. 1-receptor in cultured human lung fibroblasts. J. Clin. Invest., 101, 2080-2091.
33. 9-BK in mouse pleurisy. Br. J. Pharmacol., 123, 281-291.
34. 1 receptor antagonist. Eur. J. Pharmacol., 205, 217-218.
35. YERNENI, K.K.V., BAI, W., KHAN, B.V., MEDFORD, R.M. & NATARAJAN, R. (1999). Hyperglycemia-induced activation of nuclear transcription factor kappa B in vascular smooth muscle cells. Diabetes, 48, 855-864.